Recombinant Myosin 9 anticorps

N° du produit ABIN1169007

Détail du produit anti-Myosin 9 anticorps

Antigène: Myosin 9 (MYH9)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain, Souris, Rat, Drosophila melanogaster

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp Myosin 9 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunocytochemistry (ICC)

Specificité: Recognizes human, mouse, rat and drosophila myosin IIA (heavy chain).

Réactivité croisée: Mouche des fruits (Drosophila melanogaster), Humain, Souris, Rat (Rattus)

Purification: Purified from HEK 293 cell culture supernatant.

Pureté: >95 % (SDS-PAGE)

Immunogène: Full length myosin IIA from rat liver.

Clone: SF9

Isotype: IgG2

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

anti-Myosin IIA (non-muscle), monoclonal antibody (recombinant) (SF9) is composed of human variable regions (VH and VL) (lambda-chain) of immunoglobulin fused to the human lgG2 Fc domain.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: In PBS containing 10 % glycerol and 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 1 month after receipt when stored at +4°C. Stable for at least 1 year after receipt when stored at -20°C.

Date de péremption: 12 months

Détails sur Myosin 9

Antigène: Myosin 9 (MYH9)

Autre désignation: Myosin IIA (MYH9 Produits)

Synonymes: anticorps BDPLT6, anticorps DFNA17, anticorps EPSTS, anticorps FTNS, anticorps MHA, anticorps NMHC-II-A, anticorps NMMHC-IIA, anticorps NMMHCA, anticorps C80049, anticorps D0Jmb2, anticorps E030044M24Rik, anticorps Fltn, anticorps Myhn-1, anticorps Myhn1, anticorps NMHC II-A, anticorps NMHCIIA, anticorps NMMHC II-a, anticorps NMMHC-A, anticorps TU72.6, anticorps fi22c04, anticorps myh9, anticorps myh9l2, anticorps wu:fi22c04, anticorps wu:fj85e11, anticorps zgc:162029, anticorps zgc:66164, anticorps NMMHC, anticorps myosin, anticorps non-muscle, anticorps nonmuscle, anticorps KLG/PTK7, anticorps dfna17, anticorps epsts, anticorps ftns, anticorps nmhc-ii-a, anticorps nmmhca, anticorps myosin heavy chain 9, anticorps myosin, heavy polypeptide 9, non-muscle, anticorps myosin, heavy chain 9a, non-muscle, anticorps myosin, heavy chain 9, non-muscle, anticorps myosin, heavy chain 9, non-muscle L homeolog, anticorps MYH9, anticorps Myh9, anticorps myh9a, anticorps myh9.L

Sujet: Anti-Myosin IIA (non-muscle), monoclonal antibody (recombinant) (SF9) is an antibody developed by antibody phage display technology using a human naive antibody gene library. These libraries consist of scFv (single chain fragment variable) composed of VH (variable domain of the human immunoglobulin heavy chain) and VL (variable domain of the human immunoglobulin light chain) connected by a polypeptide linker. The antibody fragments are displayed on the surface of filamentous bacteriophage (M13). This scFv was selected by affinity selection on antigen in a process termed panning. Multiple rounds of panning are performed to enrich for antigen-specific scFv-phage. Monoclonal antibodies are subsequently identified by screening after each round of selection. The selected monoclonal scFv is cloned into an appropriate vector containing a Fc portion of interest and then produced in mammalian cells to generate an IgG like scFv-Fc fusion protein.

UniProt: P35579

Pathways: Regulation of G-Protein Coupled Receptor Protein Signaling, Integrin Complex